Kasai K, Banba N, Hishinuma A, Matsumura M, Kakishita H, Matsumura M, Motohashi S, Sato N, Hattori Y
Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan.
Am J Physiol Cell Physiol. 2000 Dec;279(6):C1859-69. doi: 10.1152/ajpcell.2000.279.6.C1859.
A cyclopentenone-type prostaglandin, 15-deoxy-Delta(12, 14)-prostaglandin J(2) (15-d-PGJ(2)), has been shown to induce the cellular stress response and to be a ligand for the peroxisome proliferator-activated receptor (PPAR)-gamma. We studied its effect on the basal and thyrotropin (TSH)-induced production of thyroglobulin (TG) by human thyrocytes cultured in the presence of 10% FBS. In 15-d-PGJ(2)-treated cells in which the agent itself did not stimulate cAMP production, both the basal production of TG and the response to TSH were facilitated, including the production of TG and cAMP, whereas such production was decreased in untreated cells according to duration of culture. PGD(2) and PGJ(2), which are precursors to 15-d-PGJ(2), exhibited an effect similar to 15-d-PGJ(2). However, the antidiabetic thiazolidinediones known to be specific ligands for PPAR-gamma, and WY-14643, a specific PPAR-alpha ligand, lacked this effect. 15-d-PGJ(2) and its precursors, but not the thiazolidinediones, induced gene expression for heme oxygenase-1 (HO-1), a stress-related protein, and strongly inhibited interleukin-1 (IL-1)-induced nitric oxide (NO) production. Cyclopentenone-type PGs have been recently shown to inhibit nuclear factor-kappaB (NF-kappaB) activation via a direct and PPAR-independent inhibition of inhibitor-kappaB kinase, suggesting that, in human thyrocytes, such PGs may inhibit IL-1-induced NO production, possibly via an inhibition of NF-kappaB activation. On the other hand, sodium arsenite, a known activator of the stress response pathway, induced HO-1 mRNA expression but lacked a promoting effect on TG production. Thus 15-d-PGJ(2) and its precursors appear to facilitate TG production via a PPAR-independent mechanism and through a different pathway from the cellular stress response that is available to cyclopentenone-type PGs. Our findings reveal a novel role of these PGs associated with thyrocyte differentiation.
一种环戊烯酮型前列腺素,15-脱氧-Δ(12,14)-前列腺素J2(15-d-PGJ2),已被证明可诱导细胞应激反应,并且是过氧化物酶体增殖物激活受体(PPAR)-γ的配体。我们研究了其对在10%胎牛血清存在下培养的人甲状腺细胞中甲状腺球蛋白(TG)基础分泌及促甲状腺激素(TSH)诱导分泌的影响。在15-d-PGJ2处理的细胞中,该药物本身不刺激环磷酸腺苷(cAMP)生成,但TG的基础分泌及对TSH的反应均增强,包括TG和cAMP的生成,而未处理的细胞中,随着培养时间的延长,此类分泌减少。15-d-PGJ2的前体PGD2和PGJ2表现出与15-d-PGJ2相似的作用。然而,已知作为PPAR-γ特异性配体的抗糖尿病噻唑烷二酮类药物,以及PPAR-α特异性配体WY-14643,均无此作用。15-d-PGJ2及其前体可诱导应激相关蛋白血红素加氧酶-1(HO-1)的基因表达,但噻唑烷二酮类药物则不能,且15-d-PGJ2及其前体可强烈抑制白细胞介素-1(IL-1)诱导的一氧化氮(NO)生成。最近发现环戊烯酮型前列腺素可通过对抑制蛋白κB激酶的直接且不依赖PPAR的抑制作用来抑制核因子κB(NF-κB)的激活,这表明在人甲状腺细胞中,此类前列腺素可能通过抑制NF-κB激活来抑制IL-1诱导的NO生成。另一方面,已知的应激反应途径激活剂亚砷酸钠可诱导HO-1信使核糖核酸(mRNA)表达,但对TG生成无促进作用。因此,15-d-PGJ2及其前体似乎通过一种不依赖PPAR的机制并通过与环戊烯酮型前列腺素所利用的细胞应激反应不同的途径来促进TG生成。我们的研究结果揭示了这些前列腺素与甲状腺细胞分化相关的新作用。